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Hyperchloraemia: ready for the big time?
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Chloride is in many ways the forgotten electrolyte. Recent evidence suggests that hyperchloraemia results in metabolic acidosis, and 
is associated with renal dysfunction, increased mortality, coagulation disturbances, splanchnic ischaemia, and a proinflammatory 
state. The renal effects and the increased mortality are the best established and most concerning of these associations. The choice 
of intravenous fluids significantly influences the development of hyperchloraemia. Further studies are required to confirm or refute 
these associations. In the interim high-chloride fluids, most commonly 0.9% saline, should be avoided as resuscitation fluids.
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Introduction
Chloride is a Cinderella electrolyte and is often viewed as a passive 
companion to sodium. A PubMed search (February 7, 2015) 
revealed 236 results for ‘hyperchloraemia’ and 3071 for ‘hyper-
natraemia’. Emerging evidence suggests, however, that chloride is 
a powerful, biologically active electrolyte in its own right and that 
hyperchloraemia is associated with adverse outcomes.
Basic science
Chloride is the major strong anion in plasma, accounting for 
two-thirds of all negative charges in plasma, and one-third of 
plasma tonicity1,2. These contributions are even greater in interstitial 
fluid as there is minimal anionic protein in this compartment. 
Normal plasma chloride is in the range of 97–107 mmol/l, with low 
intracellular concentrations of approximately 10  mmol/l1,2. Daily 
chloride intake is approximately 150 mmol, equivalent to a litre of 
0.9% saline a day1.
Although beyond the scope of this review chloride channels are 
extensively distributed and are important for a range of biological 
effects from fluid secretion to cell volume regulation and neurolog-
ical functioning1,2.
Incidence
Hyperchloraemia is common in the perioperative and critical care 
setting. A recent large cohort study in unselected postoperative 
patients reported an incidence of acute postoperative hyperchlo-
raemia of 22%3. This may rise to as high as 57.7% in selected surgical 
intensive care populations4. Severe hyperchloraemia was noted to 
occur in 6.2% of patients in a multidisciplinary intensive care unit 
(ICU)5.
Aetiology
As Table 1 shows, hyperchloraemia has multiple potential causes 
and is often multifactorial.
The question of whether our choice of intravenous fluid really influ-
ences serum chloride is key to further discussions on this topic and 
warrants further exploration.
In a study comparing the effects of just two litres of 0.9% saline 
versus Plasma-Lyte on healthy volunteers, a rapid rise in serum 
chloride was seen in the saline group and chloride levels remained 
significantly higher in the saline group than the Plasma-Lyte group 
for the four hours of the study6.
A Cochrane review of perioperative fluid therapy showed a signifi-
cantly higher plasma chloride in patients receiving 0.9% saline versus 
those receiving a balanced salt solution (114.0   vs. 106.9  mmol/l 
 p = 0.0001)7. Yunos demonstrated significantly higher mean chloride 
levels in a saline-based fluid group versus a balanced salt solution 
group5. A recent study in trauma patients resuscitated with either 
0.9% saline or a balanced salt solution showed a significantly higher 
serum chloride in the saline group: 111 vs. 104; difference: –7 (95% CI: 
–10 to –3)8. It is clear, then, that our choice of fluid influences plasma 
chloride levels; in particular the use of 0.9% saline solutions increases 
plasma chloride and puts the patient at risk of hyperchloraemia.
Does hyperchloraemia matter?
While it is now clear that hyperchloraemia is common and the 
incidence is influenced by our choice of intravenous fluid, does this 
hyperchloraemia have any adverse effects? The rest of the review 
will explore this question in further detail.
Metabolic acidosis
Hyperchloraemia has been associated with a normal anion gap 
metabolic acidosis. Although beyond the scope of this review, this 
is elegantly explained conceptually by Stewart’s hypothesis, 
whereby a relative increase in serum chloride reduces strong ion 
difference (SID), and to maintain electroneutrality the dissociation 
of water produces hydrogen ions. In this theory it is important to 
note that chloride is the driver of the acidosis and not a passive 
participant in exchange for bicarbonate as seen in more traditional 
explanations.
While theoretically attractive it must be questioned whether 
high-chloride fluids and hyperchloraemia lead to an acidosis clinically. 
Mathematical modelling, laboratory data and animal studies have 
shown that it is the relationship of the SID of the infused fluid to the 
patient’s bicarbonate or SID that determines the effect of fluid infusion 
on the subject’s acid-base status9,10. As a result of the high chloride 
content, the SID of 0.9% saline is less than that of plasma bicarbonate/
SID and thus leads to an acidosis. A fluid with an SID equal to or higher 
than the bicarbonate/SID of plasma (e.g. Ringer’s lactate) leads, 
respectively, to no change in pH or an alkalosis.
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In terms of human clinical data, Scheingraber compared fluid 
therapy in two groups of patients undergoing major gynaecolog-
ical surgery11. One group received isotonic saline at 30  ml/kg/h 
and the other received Ringer’s lactate at the same rate. The saline 
group rapidly developed hyperchloraemia and an acidosis, which 
was not seen in the Ringer’s group. At two hours the mean base 
excess had dropped from –0.4 to –6.7 mmol/l in the saline group, 
the pH from 7.41 to 7.28 and the chloride had risen from 104 to 
115 mmol/l. These are extreme fluid volumes for elective surgery 
but they graphically illustrate the point. Waters et al. demonstrated 
that hyperchloraemia was significantly correlated with an increase 
in base deficit intraoperatively12. In the Yunos study alluded to 
earlier the investigators conducted a prospective before and after 
study where they collected baseline data in their ICU for six 
months and then phased out the use of saline-based fluids5. They 
then repeated their data collection for six months and compared 
the two sets of data. Saline use fell from 2411  l in the control 
group to 52 l in the intervention group and balanced salt solution 
use increased from 469  l to 3205  l. This change was associated 
with a significant reduction in severe hyperchloraemia and a 
concomitant reduction in severe metabolic acidosis and acidae-
mia. A study in septic paediatric patients further showed that 
there is a linear relationship between chloride load and base deficit 
— in other words there is a clear dose–response relationship 
between chloride-containing fluids and acidosis13. In the trauma 
study by Young et al. the base deficit normalised within 6 h in the 
balanced salt solution group and remained in the normal range for 
the duration of the study but remained abnormal (elevated) 
throughout the 24-h study period in the 0.9% saline group8.
It is thus clear that hyperchloraemia is associated with a metabolic 
acidosis and acidotic patients tend to have poorer clinical 
outcomes14−16. It is, however, unclear whether the acidosis per se leads 
to adverse clinical outcomes or whether it is the underlying physi-
ological derangement that determines the clinical consequences. 
As an example, one of the commonly quoted adverse effects of 
acidosis is reduced myocardial contractility17,18. It appears that the 
type of acidosis may determine the degree of myocardial depression, 
with ketoacidotic patients even showing normal or increased 
myocardial contractility in some studies19−21. In terms of mortality it 
has been shown that lactate and base deficit both predict mortali-
ty but there may be poor correlation between these variables, 
suggesting that the effect of the anion and the acidosis may be 
separate15,22. In addition Gunnerson et al. demonstrated a differen-
tial mortality according to type of acidosis in a retrospective cohort 
analysis of intensive care patients. The inpatient mortality rate was 
56% for lactic acidosis, 39% for strong ion gap acidosis and 29% for 
hyperchloraemic acidosis (p < 0.001), with the baseline mortality 
rate of the entire cohort being 14%14. The exact clinical effect of the 
acidosis associated with hyperchloraemia thus remains unclear, 
but hyperchloraemic acidosis can still confound clinical manage-
ment, e.g. in a patient with diabetic ketoacidosis (DKA), receiving 
0.9% saline, a worsening acidaemia may be due to inadequate fluid 
volume or hyperchloraemia, the two scenarios requiring conflict-
ing fluid strategies. In addition emerging evidence suggests that 
hyperchloraemia itself may be problematic, beyond a simple 
acid-base effect. This will be explored further below.
Renal dysfunction
As long ago as 1983, it was shown in a canine model that hyper-
chloraemia induces renal vasoconstriction and reduces glomerular 
filtration rate (GFR). This vasoconstrictive effect was specific to the 
renal vasculature23. Chowdhury showed in human volunteers that 
two litres of 0.9% saline reduced renal artery blood flow and renal 
cortical perfusion — an effect not seen with Plasma-Lyte6.
Chowdhury also recently reported that a starch in a balanced salt 
solution increased renal cortical perfusion versus a saline-based 
starch24. In another volunteer study, subjects given Hartmann’s 
solution showed an earlier time to first micturition and a greater 
urine output over six hours than patients given 0.9% saline. This 
greater diuresis has been ascribed to the lower osmolality of 
Hartmann’s solution causing reduced vasopressin secretion. This is 
unlikely to be the sole explanation though, as the Hartmann’s 
group also had a greater sodium excretion which suggests a 
primarily renal effect — possibly due to the difference in chloride 
load25. In a follow-up paper to Yunos’s initial study evaluating the 
biochemical effects of restricting chloride-rich fluids the investiga-
Table 1: Aetiology of hyperchloraemia
Cause Examples
Chloride infusion Administration of chloride-rich fluids e.g. 0.9% sodium chloride
Total parenteral nutrition










Definite or relative increase in tubular chloride reabsorption Renal tubular acidosis





Note: Modified from Yunos et al.1
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tors evaluated the effect of this change in fluid therapy on clinical 
outcomes. They reported a significant reduction in acute kidney 
injury (AKI) and renal replacement therapy (RRT) in the chloride- 
restrictive group26. While these are only observational data this is 
amongst the first evidence that changing our choice of fluid and 
restricting chloride-containing fluids can change clinical 
outcomes. A recently published observational study in liver trans-
plant recipients identified the use of large volumes of chloride-rich 
fluids as an independent predictor of AKI27. In contrast, the 
Cochrane review mentioned above suggested no difference in 
renal dysfunction and RRT between the chloride-rich and bal-
anced salt groups7. It evaluated randomised studies of buffered vs. 
non-buffered fluids for perioperative fluid resuscitation up to May 
2011, and included data from 14 publications. Of these only three 
(n = 207) reported on ‘renal insufficiency requiring support’, seven 
(n = 399) reported intraoperative urine output, and three (n = 222) 
reported postoperative creatinine clearance. In addition five stud-
ies reported various creatinine-based indices but there were only 
two studies per category (n = 113–151). This review thus included 
small numbers and did not specifically evaluate the development 
of AKI using current standard definitions; therefore the results 
regarding renal dysfunction should be viewed with caution.
Splanchnic circulation
Concerns have also been raised over the effects of hyperchloraemia 
on the splanchnic circulation. A volunteer crossover study raised 
initial concerns with an increased incidence of abdominal discom-
fort in the 0.9% saline versus the Ringer’s lactate group28. A subse-
quent study on elderly surgical patients demonstrated a higher 
gastric tonometry CO2 gap in the saline versus the balanced-salt 
group29. This suggests reduced gastric perfusion in the saline group. 
Interestingly abdominal symptoms are key features of ammonium 
chloride poisoning, suggesting a link between chloride and the above 
findings. While current evidence is limited, gut hypoperfusion and 
bacterial translocation may predispose patients to septic complica-
tions and this is thus an area of concern and should be a focus for 
future research30−33.
Sepsis
There are also concerns about the effects of hyperchloraemia in 
sepsis, although the evidence is limited to laboratory data and 
animal studies. Studies in rat models of septic shock have shown a 
worse acid-base profile in animals receiving 0.9% saline as opposed 
to lower chloride solutions34. The same group also demonstrated a 
significant correlation between an increase in chloride levels and 
hypotension in their rat model35. Investigating the cause of these 
findings the researchers found that hyperchloraemic acidosis 
induced increased NF-kB DNA binding, increased nitric oxide 
release, and increased interleukin (IL) 6: IL 10 ratios in cell culture, 
suggesting a proinflammatory effect at the cellular level36. Further 
research on this in a rat model confirmed that hyperchloraemic 
acidosis was associated with an increased cytokine release as 
compared with controls resuscitated with Ringer’s lactate37. While 
this animal research suggests that hyperchloraemia has adverse 
haemodynamic and inflammatory effects in sepsis we simply do 
not have human data to confirm or refute these findings.
Haemostasis and haemorrhage
The effect of hyperchloraemic fluids on haemostasis and haemor-
rhage has also been investigated.
In a series of studies by Roche and James, saline-based starches 
appeared to impair coagulation to a greater degree than equivalent 
balanced salt solution starches and Ringer’s lactate38,39. This appears 
not to be related to differences in calcium content between fluids, 
which leaves us to hypothesise about the role of primary chloride or 
secondary acid-base differences being the driving factor40. In terms 
of clinical studies, Martin showed that in patients undergoing major 
surgery those who received a starch in saline had a hypocoagulable 
thromboelastograph (TEG) compared with those who received a 
starch in a balanced salt solution, whereas those who received 
Ringer’s lactate tended to develop a hypercoagulable state41. In a 
trial involving patients undergoing major surgery, those who 
received a saline-based colloid had significant TEG abnormalities 
and increased blood loss compared with those receiving a 
balanced salt-solution colloid42. In a study involving patients under-
going abdominal aortic aneurysm repair, those who received 0.9% 
saline had greater blood loss and received more blood products 
than those who received Ringer’s lactate43. In contrast to the above, 
there was no difference in the international normalised ratio and 
activated partial thromboplastin time in trauma patients resuscitated 
with either 0.9% saline or Plasma-Lyte A8. This study did not, howev-
er, use the TEG. The data are thus by no means conclusive but do 
raise a concern regarding the potential for chloride-rich fluids to 
impair coagulation. Further clinical studies, either removing the 
confounder of colloid-based fluids or using modern colloids, and 
using the TEG as a standardised assessment of coagulation, are 
warranted.
Mortality
While the basic science, animal studies and human surrogate 
outcome/organ dysfunction studies have raised concerns about 
hyperchloraemia, is there any evidence of an effect on mortality in 
human studies?
The Cochrane review mentioned previously included only three 
trials that reported mortality outcomes and showed no difference 
in mortality in perioperative patients whether they received saline 
or a balanced salt solution7.
Yunos’s study, which highlighted the effect of high-chloride fluids 
on AKI and RRT, also did not demonstrate a mortality difference26.
In contrast to this is a thought-provoking study from Brazil44. The 
authors prospectively evaluated major surgical patients who 
required postoperative intensive care. They recruited 393 patients 
and analysed their postoperative chloride levels. Instead of using 
standard definitions of hyperchloraemia they constructed a 
receiver operating characteristic curve of chloride levels and hos-
pital mortality. This showed an optimal cut-off point of 114 mmol/l 
and a reasonable area under the curve (AUC) for predicting death 
of 0.76. Using this cut-off, 31.7% of the patients were hyperchlo-
raemic. Comparing mortality between those above and below 
the cut-off they found a significantly higher mortality in the 
hyperchloraemic patients (19.3 vs. 7.4%; p = 0.001). These 
patients, however, had significantly longer surgery and received 
more intraoperative saline. Based on this it cannot be said whether 
the hyperchloraemia is causative or merely a marker of 
increased risk but it does raise serious concerns regarding the 
potential risks of iatrogenic hyperchloraemia.
In another Brazilian study, Boniatti evaluated a number of acid-base 
and biochemical variables as predictors of mortality in ICU4. While 
many showed an association on univariate analysis, only chloride and 
albumin remained significant on multivariate analysis and improved 
the predictive ability of a multiple logistic regression model 
consisting of SOFA score and age, increasing the AUC from 0.72 to 0.8. 
Again we have hyperchloraemia as a significant marker of poor 
outcome but no clarity on cause and effect.
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Most recently, McCluskey reported that acute postoperative hyperchlo-
raemia was associated with an increased risk of 30-day mortality (3.4 vs. 
1.3%; p < 0.01). This was a large retrospective cohort study involving over 
22 000 patients who underwent inpatient non-cardiac, non- 
transplant surgery. The study also included propensity matching of 
hyperchloraemic and non-hyperchloraemic patients. The excess 
mortality in hyperchloraemic patients was still seen in this propensi-
ty-matched cohort (3.0 vs. 1.9%; p < 0.01). Hyperchloraemia was found 
to be an independent predictor of mortality in multiple logistic regres-
sion analysis (odds ratio = 2.049; 95% CI 1.619–2.592; p < 0.01).
While not conclusive, this association with mortality raises serious 
concerns and needs to be explored further.
Conclusion
Hyperchloraemia leads to the development of metabolic acidosis 
and is associated with adverse renal effects and increased mortality, 
amongst other adverse effects. It is also apparent that our choice of 
intravenous fluids influences the development of hyperchloraemia. 
From a research perspective we need to explore further the associa-
tion between hyperchloraemia and adverse  outcomes in different 
populations and attempt to elucidate whether the hyperchloraemia 
is indeed contributing to any associated  adverse outcomes in the 
clinical setting. We also need to explore whether preventing or 
treating hyperchloraemia results in improved clinical outcomes. In 
the interim it is prudent to avoid the use of 0.9% saline as a resuscita-
tion fluid, and to avoid often unconsidered sources of chloride where 
possible, e.g. the use of colloids in 0.9% saline and the use of 0.9% 
saline as a diluent for large-volume medication infusions.
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